Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 40
Titolo Data di pubblicazione Autore(i) Rivista Editore
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 1-gen-2021 Simola, Nicola; Pinna, Annalisa; Frau, Lucia; Costa, Giulia; Marongiu, Jacopo; Parekh, Pathik; Serra, Marcello; Morelli, Micaela - Springer
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence 1-gen-2017 Cadoni, Cristina; Pisanu, Augusta; Simola, Nicola; Frau, Lucia; Porceddu, PIER FRANCESCA; Corongiu, Silvia; Dessi', Christian; Sil, Annesha; Plumitallo, Antonio; Wardas, Jadwiga; DI CHIARA, Gaetano NEUROPHARMACOLOGY -
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain 1-gen-2016 Frau, Lucia; Simola, Nicola; Porceddu, PIER FRANCESCA; Morelli, Micaela NEUROTOXICOLOGY -
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent 1-gen-2016 Frau, Lucia; Costa, Giulia; Porceddu, Pier Francesca; Khairnar, Amit; Castelli, Maria Paola; Ennas, Maria Grazia; Madeddu, Camilla; Wardas, Jadwiga; Morelli, Micaela JOURNAL OF NEUROCHEMISTRY -
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease 1-gen-2016 Baranyi, M; Porceddu, PIER FRANCESCA; Goloncser, F; Kulcsar, S; Otrokocsi, L; Kittel, A; Pinna, Annalisa; Frau, Lucia; Huleatt, P. b.; Khoo, Ml; Chai, C. l. l.; Dunkel, P; Matyus, P; Morelli, Micaela; Sperlagh, B. MOLECULAR NEURODEGENERATION -
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 1-gen-2014 Simola, Nicola; Pinna, Annalisa; Frau, Lucia; Morelli, Micaela - Springer
Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of 3,4-Methylendioxymethamphetamine (MDMA) on Glial Activation in the Mouse Brain: Relevance to Caffeine-MDMA Interactions 1-gen-2014 Khairnar, A; Frau, Lucia; Plumitallo, Antonio; Morelli, Micaela; Simola, Nicola JOURNAL OF CAFFEINE RESEARCH -
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: Implications for the study of the affective properties of drugs of abuse 1-gen-2014 Simola, Nicola; Frau, Lucia; Plumitallo, Antonio; Morelli, Micaela INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY -
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease 1-gen-2013 Pinna, Annalisa; Simola, Nicola; Frau, Lucia; Morelli, Micaela - Springer Science
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility 1-gen-2013 Frau, Lucia; Simola, Nicola; Plumitallo, Antonio; Morelli, Micaela JOURNAL OF NEUROCHEMISTRY -
Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs 1-gen-2013 Frau, Lucia; Simola, Nicola; Morelli, Micaela JOURNAL OF CAFFEINE RESEARCH -
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses 1-gen-2013 Simola, Nicola; Morelli, Micaela; Frazzitta, G; Frau, Lucia FRONTIERS IN COMPUTATIONAL NEUROSCIENCE -
Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons 1-gen-2013 Frau, Lucia; Morelli, Micaela; Simola, Nicola EXPERIMENTAL NEUROLOGY -
MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice 1-gen-2013 Costa, Giulia; Frau, Lucia; Wardas, J; Pinna, A; Plumitallo, Antonio; Morelli, Micaela MOVEMENT DISORDERS -
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice 1-gen-2012 Baiguera, C; Alghisi, M; Pinna, Annalisa; Bellucci, A; DE LUCA, MARIA ANTONIETTA; Frau, Lucia; Morelli, Micaela; Ingrassia, R; Benarese, M; Porrini, V; Pellitteri, M; Bertini, G; Fabene, Pf; Sigala, S; Spillantini, Mg; Liou, Hc; Spano, Pf; Pizzi, M. BRAIN -
Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective? 1-gen-2012 Morelli, Micaela; Frau, Lucia; Simola, Nicola EXPERIMENTAL NEUROLOGY -
PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests nigrostriatal degeneration in a progressive Parkinson’s disease model. 1-gen-2011 Carta, Annarosa; Pisanu, A; Frau, Lucia; Spiga, Saturnino; Carboni, Ezio SOC. NEUROSCI. ABSTR., 41TH ANNUAL MEETING SOCIETY FOR NEUROSCIENCE, WASHINGTON D.C., 12-16 NOVEMBRE 2011 Society for Neuroscience
A442 PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests neurodegeneration in a progressive Parkinson´s disease model 1-gen-2011 Carta, Annarosa; Pisanu, A; Frau, Lucia; Spiga, Saturnino; Carboni, Ezio - International brain resesearch organization
Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain 1-gen-2011 Khairnar, A; Frau, Lucia; Fenu, Sandro; Plumitallo, A; Morelli, M. - -
Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age 1-gen-2011 Frau, Lucia; Khairnar, A; Fenu, Sandro; Morelli, M. - -
Mostrati risultati da 1 a 20 di 40
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile